The Medical Affairs Professional Society (MAPS), a distinguished non-profit organization recognized under 501(c)(3), proudly announces the appointment of Robin Winter-Sperry, MD as the new President ...

He owns stock in Johnson & Johnson, Eli Lilly, Merck, Procter & Gamble, and Schering-Plough. Dr. Kvien has received clinical research support from Merck, Searle, Aventis Pharma, and Schering-Plough.

In the summer of 1999 he obtained the Schering-Plough Newman Scholarship in Organic Chemistry at University College Dublin for a period of three years. His work in Ireland centered on cyclodextrins as ...

Organon was then acquired by Schering-Plough in 2007, which was in turn snapped up in 2009 by US-based Merck & Co. The big US pharma saw the potential of the drug after promising results from ...

who has been on the board of Merck and predecessor Schering-Plough since 1995. Another 17 took at least one of their seats within the past year or so, including Marissa Mayer, the former Yahoo ...

Feel free to distribute or cite this material, but please credit OpenSecrets. For permission to reprint for commercial uses, such as textbooks, contact OpenSecrets: [email protected] ...

We're aiming for 100 new donors and $10,000 raised by May 31 — make your first gift today to support transparency in politics. OpenSecrets is 100% funded through donations.

Cactus Companies has agreed to acquire a 65% controlling stake in Baker Hughes' Surface Pressure Control (SPC) business. The ...

Cactus Inc. will acquire 65% of Baker Hughes' Surface Pressure Control business, valued at $344.5M. The joint venture aims to ...

Cristcot, a clinical-stage pharmaceutical company advancing innovative therapies for gastrointestinal diseases, today announced the appointment of Richard Kim to the role of Chief Commercial Officer.

Get the detailed quarterly/annual income statement for Merck & Co., Inc. (MRK). Find out the revenue, expenses and profit or loss over the last fiscal year.